sitagliptin/metformin hydrochloride teva
teva gmbh - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and sitagliptin
sitagliptin/metformin hydrochloride sandoz
sandoz d.d. - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and sitagliptin
sitagliptin/metformin hydrochloride sandoz
sandoz d.d. - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and sitagliptin
sitagliptin/metformin hydrochloride grindeks
as grindeks - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and sitagliptin
sitagliptin/metformin hydrochloride grindeks
as grindeks - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and sitagliptin
vildagliptin/metformin hydrochloride elvim
sia elvim - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and vildagliptin
vildagliptin/metformin hydrochloride elvim
sia elvim - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and vildagliptin
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - plaučių liga, lėtinė obstrukcinė - vaistai nuo obstrukcinių kvėpavimo takų ligų, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - vaistai nuo obstrukcinių kvėpavimo takų ligų, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
duaklir genuair
covis pharma europe b.v. - aclidinium bromidas, formoterol fumarate dihidratas - plaučių liga, lėtinė obstrukcinė - vaistai nuo obstrukcinių kvėpavimo takų ligų, - duakliras genuair yra nurodomas kaip palaikomasis bronchodilatatorius, skirtas simptomų palengvinimui suaugusiems pacientams, sergantiems lėtiniu obstrukcine plaučių liga (lopl).